Michael Mashaal

Michael Mashaal is a highly accomplished professional in the healthcare and biotechnology industry. He holds a Doctor of Medicine (MD) degree from Stony Brook University Health Sciences Center School of Medicine and a Bachelor's degree in Biology from Emory University.

Currently, Michael Mashaal serves as the Managing Director at Healthcare Venture Partners, where he leverages his expertise and experience to drive innovation and growth in the healthcare sector. His vast knowledge and strategic vision make him a valuable asset in the industry.

With an impressive track record, Michael Mashaal has held various key positions in renowned organizations. He has served as the Chairman of the Board at Orphion Therapeutics, demonstrating his strong leadership skills and ability to guide organizations towards success.

Michael Mashaal's professional journey also includes roles such as Board Member at MyOme, Board Observer at Heartflow, Inc, Managing Director at HealthCor Partners Management, L.P., and other important positions in the healthcare and biotechnology domain.

Prior to his current roles, Michael Mashaal has been associated with esteemed organizations like Paradigm Spine, LLC, ReShape Lifesciences Inc., Natera, Velcera, Corindus Vascular Robotics, ApaTech, and has served as a Senior Biotechnology Analyst at HealthCor Management, L.P. and SAC HealthCo.

His career highlights also encompass experience as a Healthcare Analyst at Paramount Capital Asset Management and as a General Surgery Resident at Stony Brook University Hospital, reflecting his diverse skill set and dedication to the field of healthcare.